Veeva's laser focus on the life sciences industry has made it a leader in this corner of the cloud market. The company could grow its revenue -- and share price -- at a good clip in the next four ...
Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be ...
The past six months have been rough for Veeva Systems (NYSE: VEEV). The stock has declined 35% over this period as the market fears that mounting competition will lead to disappointing financial ...
Veeva Systems Inc. (NYSE:VEEV) Q1 2026 Earnings Call Transcript May 28, 2025 Veeva Systems Inc. beats earnings expectations. Reported EPS is $1.97, expectations were $1.74. Operator: Ladies and ...
As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for domination of big pharma CRM, it began the first massive use case for adoption of ...
Cloud computing leaders are among the largest and most successful companies in the world. Competing with them is challenging, especially for smaller players. However, Veeva Systems’ (NYSE: VEEV) ...
Veeva Systems has been a solid growth stock in the recent past and is still worth considering for a long-term portfolio. Cloud computing leaders are among the largest and most successful companies in ...
When Netflix launched "Pacific Rim: The Black" back in 2021, it wasn't about adding yet another anime to the streaming pile; it was about daring to reimagine the well-known universe through the lens ...
The National Park Service said hotels on the South Rim could again welcome guests starting on Wednesday after repairs to a broken water pipeline. By Gabe Castro-Root Eleven days after hastily shutting ...
Veeva Systems is rated a buy, with strong revenue and EPS growth, raised FY2026 guidance, and a misunderstood sell-off creating a long-term opportunity. VEEV's migration to Vault CRM is progressing ...
As Veeva and Salesforce go their separate ways, why it's all to play for in the Life Sciences market
Our CRM business is healthy, and it is an important part of Veeva, but it's not the major -- it's not the largest part of Veeva anymore, that’s for sure. A significant statement from Peter Gassner, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results